CytoMed Therapeutics Limited GDTC
0.96
0.05
5.49%
as of 25 Sep
- Market cap
- $10.8M
- P/E
- 0.0×
Follow GDTC
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Jun '25 | Dec '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% |
+6 more TTM periods Free account |
|
| 0.00% | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(9.19) | (8.47) | (8.45) | (6.84) | |
Capital Expenditures |
(2.22) | (1.77) | (1.51) | (0.84) | |
| Other line items | |||||
Cash ROIC |
(95.20%) | (80.75%) | (65.55%) | (47.68%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.18 | 0.29 | 0.22 | 0.47 | |
Capex/Depreciation |
(2.71) | (2.22) | (1.87) | (0.98) | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates